Computers in Biology and Medicine,
Journal Year:
2020,
Volume and Issue:
129, P. 104135 - 104135
Published: Nov. 23, 2020
The
aim
of
this
study
was
to
develop
radiomics-based
machine
learning
models
based
on
extracted
radiomic
features
and
clinical
information
predict
the
risk
death
within
5
years
for
prognosis
clear
cell
renal
carcinoma
(ccRCC)
patients.According
image
quality
data
availability,
we
eventually
selected
70
ccRCC
patients
that
underwent
CT
scans.
Manual
volume-of-interest
(VOI)
segmentation
each
performed
by
an
experienced
radiologist
using
3D
slicer
software
package.
Prior
feature
extraction,
pre-processing
images
extract
different
features,
including
wavelet,
Laplacian
Gaussian,
resampling
intensity
values
32,
64
128
bin
levels.
Overall,
2544
radiomics
were
from
VOI
patient.
Minimum
Redundancy
Maximum
Relevance
(MRMR)
algorithm
used
as
selector.
Four
classification
algorithms
used,
Generalized
Linear
Model
(GLM),
Support
Vector
Machine
(SVM),
K-nearest
Neighbor
(KNN)
XGBoost.
We
Bootstrap
method
create
validation
sets.
Area
under
receiver
operating
characteristic
(ROC)
curve
(AUROC),
accuracy,
sensitivity,
specificity
assess
performance
models.The
best
single
among
8
achieved
XGBoost
model
a
combination
(AUROC,
with
95%
confidence
interval
0.95-0.98,
0.93-0.98,
0.93-0.96
~1.0,
respectively).We
developed
robust
classifier
is
capable
accurately
predicting
overall
survival
RCC
patients.
This
signature
may
help
identifying
high-risk
who
require
additional
treatment
follow
up
regimens.
Radiology,
Journal Year:
2020,
Volume and Issue:
295(2), P. 328 - 338
Published: March 10, 2020
The
image
biomarker
standardisation
initiative
(IBSI)
is
an
independent
international
collaboration
which
works
towards
standardising
the
extraction
of
biomarkers
from
acquired
imaging
for
purpose
high-throughput
quantitative
analysis
(radiomics).
Lack
reproducibility
and
validation
studies
considered
to
be
a
major
challenge
field.
Part
this
lies
in
scantiness
consensus-based
guidelines
definitions
process
translating
into
biomarkers.
IBSI
therefore
seeks
provide
nomenclature
definitions,
benchmark
data
sets,
values
verify
processing
calculations,
as
well
reporting
guidelines,
analysis.
Medical Physics,
Journal Year:
2020,
Volume and Issue:
47(5)
Published: May 1, 2020
Radiomics
is
an
emerging
area
in
quantitative
image
analysis
that
aims
to
relate
large‐scale
extracted
imaging
information
clinical
and
biological
endpoints.
The
development
of
methods
along
with
machine
learning
has
enabled
the
opportunity
move
data
science
research
towards
translation
for
more
personalized
cancer
treatments.
Accumulating
evidence
indeed
demonstrated
noninvasive
advanced
analytics,
is,
radiomics,
can
reveal
key
components
tumor
phenotype
multiple
three‐dimensional
lesions
at
time
points
over
beyond
course
treatment.
These
developments
use
CT,
PET,
US,
MR
could
augment
patient
stratification
prognostication
buttressing
targeted
therapeutic
approaches.
In
recent
years,
deep
architectures
have
their
tremendous
potential
segmentation,
reconstruction,
recognition,
classification.
Many
powerful
open‐source
commercial
platforms
are
currently
available
embark
new
areas
radiomics.
Quantitative
research,
however,
complex
statistical
principles
should
be
followed
realize
its
full
potential.
field
particular,
requires
a
renewed
focus
on
optimal
study
design/reporting
practices
standardization
acquisition,
feature
calculation,
rigorous
forward.
this
article,
role
as
major
computational
vehicle
model
building
radiomics‐based
signatures
or
classifiers,
diverse
applications,
working
principles,
opportunities,
radiomics
will
reviewed
examples
drawn
primarily
from
oncology.
We
also
address
issues
related
common
applications
medical
physics,
such
standardization,
extraction,
building,
validation.
Insights into Imaging,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: May 4, 2023
Even
though
radiomics
can
hold
great
potential
for
supporting
clinical
decision-making,
its
current
use
is
mostly
limited
to
academic
research,
without
applications
in
routine
practice.
The
workflow
of
complex
due
several
methodological
steps
and
nuances,
which
often
leads
inadequate
reporting
evaluation,
poor
reproducibility.
Available
guidelines
checklists
artificial
intelligence
predictive
modeling
include
relevant
good
practices,
but
they
are
not
tailored
radiomic
research.
There
a
clear
need
complete
checklist
study
planning,
manuscript
writing,
evaluation
during
the
review
process
facilitate
repeatability
reproducibility
studies.
We
here
present
documentation
standard
research
that
guide
authors
reviewers.
Our
motivation
improve
quality
reliability
and,
turn,
name
CLEAR
(CheckList
EvaluAtion
Radiomics
research),
convey
idea
being
more
transparent.
With
58
items,
should
be
considered
standardization
tool
providing
minimum
requirements
presenting
In
addition
dynamic
online
version
checklist,
public
repository
has
also
been
set
up
allow
community
comment
on
items
adapt
future
versions.
Prepared
revised
by
an
international
group
experts
using
modified
Delphi
method,
we
hope
will
serve
well
as
single
scientific
reviewers
literature.
European Journal of Nuclear Medicine and Molecular Imaging,
Journal Year:
2019,
Volume and Issue:
46(13), P. 2656 - 2672
Published: June 18, 2019
The
aim
of
this
systematic
review
was
to
analyse
literature
on
artificial
intelligence
(AI)
and
radiomics,
including
all
medical
imaging
modalities,
for
oncological
non-oncological
applications,
in
order
assess
how
far
the
image
mining
research
stands
from
routine
application.
To
do
this,
we
applied
a
trial
phases
classification
inspired
drug
development
process.
Among
articles
considered
inclusion
PubMed
were
multimodality
AI
radiomics
investigations,
with
validation
analysis
aimed
at
relevant
clinical
objectives.
Quality
assessment
selected
papers
performed
according
QUADAS-2
criteria.
We
developed
criteria
studies.
Overall
34,626
retrieved,
300
applying
inclusion/exclusion
criteria,
171
high-quality
(QUADAS-2
≥
7)
identified
analysed.
In
27/171
(16%),
141/171
(82%),
3/171
(2%)
studies
an
AI-based
algorithm,
model,
combined
radiomics/AI
approach,
respectively,
described.
A
total
26/27(96%)
1/27
(4%)
classified
as
phase
II
III,
respectively.
Consequently,
13/141
(9%),
10/141
(7%),
111/141
(79%),
7/141
(5%)
0,
I,
II,
All
three
categorised
trials.
results
are
promising
but
still
not
mature
enough
tools
be
implemented
setting
widely
used.
transfer
learning
well-known
process,
some
specific
adaptations
discipline
could
represent
most
effective
way
algorithms
become
standard
care
tools.
Scientific Reports,
Journal Year:
2019,
Volume and Issue:
9(1)
Published: Jan. 24, 2019
Image
features
need
to
be
robust
against
differences
in
positioning,
acquisition
and
segmentation
ensure
reproducibility.
Radiomic
models
that
only
include
can
used
analyse
new
images,
whereas
with
non-robust
may
fail
predict
the
outcome
of
interest
accurately.
Test-retest
imaging
is
recommended
assess
robustness,
but
not
available
for
phenotype
interest.
We
therefore
investigated
18
methods
determine
feature
robustness
based
on
image
perturbations.
perturbation
were
compared
4032
computed
from
gross
tumour
volume
two
cohorts
tomography
imaging:
I)
31
non-small-cell
lung
cancer
(NSCLC)
patients;
II):
19
head-and-neck
squamous
cell
carcinoma
(HNSCC)
patients.
Robustness
was
measured
using
intraclass
correlation
coefficient
(1,1)
(ICC).
Features
ICC$\geq0.90$
considered
robust.
The
NSCLC
cohort
contained
more
test-retest
than
HNSCC
($73.5\%$
vs.
$34.0\%$).
A
chain
consisting
noise
addition,
affine
translation,
growth/shrinkage
supervoxel-based
contour
randomisation
identified
fewest
false
positive
(NSCLC:
$3.3\%$;
HNSCC:
$10.0\%$).
Thus,
this
robustness.
Journal of Cardiovascular Magnetic Resonance,
Journal Year:
2019,
Volume and Issue:
21(1), P. 61 - 61
Published: Jan. 1, 2019
Machine
learning
(ML)
is
making
a
dramatic
impact
on
cardiovascular
magnetic
resonance
(CMR)
in
many
ways.
This
review
seeks
to
highlight
the
major
areas
CMR
where
ML,
and
deep
particular,
can
assist
clinicians
engineers
improving
imaging
efficiency,
quality,
image
analysis
interpretation,
as
well
patient
evaluation.
We
discuss
recent
developments
field
of
ML
relevant
acquisition
&
reconstruction,
analysis,
diagnostic
evaluation
derivation
prognostic
information.
To
date,
main
has
been
significantly
reduce
time
required
for
segmentation
analysis.
Accurate
reproducible
fully
automated
quantification
left
right
ventricular
mass
volume
now
available
commercial
products.
Active
research
include
reduction
reconstruction
time,
spatial
temporal
resolution,
perfusion
myocardial
mapping.
Although
large
cohort
studies
are
providing
valuable
data
sets
training,
care
must
be
taken
extending
applications
specific
groups.
Since
algorithms
fail
unpredictable
ways,
it
important
mitigate
this
by
open
source
publication
computational
processes
datasets.
Furthermore,
controlled
trials
needed
evaluate
methods
across
multiple
centers